Solaraze

Solaraze is a prescription topical gel containing 3% diclofenac sodium, a nonsteroidal anti-inflammatory drug (NSAID). It is used to treat actinic keratoses, which are rough, scaly, precancerous patches of skin caused by chronic sun exposure.

Dosage by Body Weight

Apply to affected skin areas twice daily. Gently smooth the gel onto the lesions. The typical duration of therapy is 60 to 90 days. Avoid applying to open wounds, infected skin, or exfoliative dermatitis.

  1. Body Weight
    Below 5 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness of Solaraze in pediatric patients have not been established.
  2. Body Weight
    5-7 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness of Solaraze in pediatric patients have not been established.
  3. Body Weight
    8-10 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness of Solaraze in pediatric patients have not been established.
  4. Body Weight
    11-15 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness of Solaraze in pediatric patients have not been established.
  5. Body Weight
    16-20 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness of Solaraze in pediatric patients have not been established.

Formulation

Topical Gel

Purpose

Treatment of actinic keratosis (AK) in adults

Generic Name

Diclofenac sodium 3%

Scheduled Drug

No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.

Alternatives

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.